• OPEN AN ACCOUNT
Indian Indices
Nifty
25,069.20 -44.80
(-0.18%)
Sensex
81,785.74 -118.96
( -0.15%)
Bank Nifty
54,887.85 78.55
( 0.14%)
Nifty IT
35,902.20 -208.55
( -0.58%)
Global Indices
Nasdaq
45,857.35 271.66
(-0.59%)
Dow Jones
6,605.38 -3.09
(-0.05%)
Hang Seng
44,778.02 405.52
(0.91%)
Nikkei 225
9,283.29 -14.29
(-0.15%)
Forex
USD-INR
88.28 0.18
(0.20%)
EUR-INR
103.39 0.27
(0.26%)
GBP-INR
119.55 0.32
(0.27%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
136.1849241
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
26.18
4685.47
EPS(TTM)
Face Value()
Div & Yield %
19.47
10
0.19
 

jindal stainless ltd
Navin Fluorine International update upcoming cGMP-4 facility at Dewas
Sep 04,2025
Navin Fluorine International announced that Phase 1 of cGMP-4 with a capital expenditure of ~ Rs. 160 crore has achieved commissioning readiness today with validation batches having commenced for the company's European partner. The aforesaid refers to the capital expenditure of Rs. 288 crore for new cGMP-4 facility at Dewas.